Aptus Clinical and the Cell and Gene Therapy Catapult Announce Their Clinical Service Partnership


Applied Clinical Trials

CRO Aptus Clinical has been appointed as a supplier for clinical services by the Cell and Gene Therapy Catapult (CGTC). As an early-phase CRO, its role is to support development and delivery of advanced therapy studies in the UK and Europe. Through this partnership, Aptus Clinical will primarily provide dedicated site set-up and monitoring of investigational sites for the CGTC’s collaborators.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.